<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVEThe recommended HbA(1c) diagnostic categories remain controversial and their utility in doubt in pediatrics </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesized that alterations in the pathophysiologic mechanisms of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> may be evident in the American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association recommended at-risk/<z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> category (HbA(1c) 5.7 to &lt;6.5%).RESEARCH DESIGN AND METHODSWe compared in vivo hepatic and peripheral insulin sensitivity by [6,6-(2)H(2)] <z:chebi fb="105" ids="17234">glucose</z:chebi> and a 3-h hyperinsulinemic-euglycemic clamp and β-cell function by a 2-h hyperglycemic clamp (∼225 mg/dL) in overweight/<z:mp ids='MP_0001261'>obese</z:mp> (BMI ≥85th percentile) adolescents with <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> (HbA(1c) 5.7 to &lt;6.5%) (n = 160) to those with <z:mpath ids='MPATH_458'>normal</z:mpath> HbA(1c) (&lt;5.7%) (n = 44). β-Cell function was expressed relative to insulin sensitivity (i.e., the disposition index = insulin sensitivity × first-phase insulin).RESULTSIn the <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> versus <z:mpath ids='MPATH_458'>normal</z:mpath> HbA(1c) category, fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin, and oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) area under the curve for <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin were significantly higher; hepatic and peripheral insulin sensitivity were lower; and β-cell function relative to insulin sensitivity was lower (366 ± 48 vs. 524 ± 25 mg/kg/min; P = 0.005) </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 27% of youth in the <z:mpath ids='MPATH_458'>normal</z:mpath> HbA(1c) category and 41% in the <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> HbA(1c) category had dysglycemia (impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and/or <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo>) by a 2-h OGTT.CONCLUSIONSOverweight/<z:mp ids='MP_0001261'>obese</z:mp> adolescents with HbA(1c) in the at-risk/<z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> category demonstrate impaired β-cell function relative to insulin sensitivity, a metabolic marker for heightened risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, HbA(1c) may be a suitable screening tool in large-scale epidemiological observational and/or interventional studies examining the progression or reversal of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> risk </plain></SENT>
</text></document>